Morristown, NJ, United States of America

Richard Nause

This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2020-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard Nause. Retrieved from https://idiyas.com/inventor/richard-nause

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Richard Nause in Pharmaceutical Science

Introduction

Richard Nause, an accomplished inventor based in Morristown, NJ, has made significant contributions to the field of pharmaceuticals. With two patents to his name, Nause is recognized for his research and development of innovative treatments that aim to improve patient health and outcomes.

Latest Patents

One of Richard Nause's latest patents focuses on "Pharmaceutical compositions containing a DGAT1 inhibitor." This invention relates to a pharmaceutical composition that incorporates a DGAT1 inhibitor, which plays a crucial role in addressing various health issues. The details of this invention signify a potential breakthrough in the realm of medical treatments and therapeutic approaches.

Career Highlights

Nause works with Novartis AG, a renowned global healthcare company that specializes in innovative pharmaceuticals and treatments. Over the years, he has dedicated his career to advancing the field of medicine, leveraging his expertise to develop solutions that can potentially enhance the quality of life for many individuals.

Collaborations

Throughout his career, Richard Nause has collaborated with esteemed colleagues such as Hong Wen and Natrajan Kumaraperumal. These partnerships reflect the collaborative nature of innovation within the pharmaceutical industry, where diverse minds work together to bring forth groundbreaking solutions.

Conclusion

In summary, Richard Nause stands out as a significant figure in pharmaceutical innovations. His work with DGAT1 inhibitors exemplifies his commitment to advancing medical science, while his collaborations with talented coworkers highlight the importance of teamwork in the inventive process. As the industry continues to evolve, Nause's contributions will undoubtedly play a vital role in shaping the future of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…